Sarepta Therapeutics, Inc. (BMV:SRPT)

Sarepta Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	40,067	219,088	168,071	211,918	145,892	251,636
Market Cap Growth	-82.81%	30.35%	-20.69%	45.26%	-42.02%	39.48%
Enterprise Value	50,529	218,619	160,582	204,713	127,715	235,538
PE Ratio	-	51.96	-16.63	-16.14	-17.49	-23.98
Forward PE	12.97	15.47	-	-	-	-
PS Ratio	0.86	6.19	7.27	12.21	11.18	25.06
PB Ratio	1.57	7.71	10.52	29.61	8.45	17.76
P/TBV Ratio	33.10	8.59	10.37	29.47	7.89	17.45
P/FCF Ratio	-	-27.87	-15.66	-32.00	-16.29	535.64
P/OCF Ratio	-	-41.23	-18.04	-35.03	-17.70	125.92
EV/Sales Ratio	1.10	6.18	6.95	11.80	9.79	23.45
EV/EBITDA Ratio	16.88	45.96	-38.65	-22.27	-16.29	-23.58
EV/EBIT Ratio	-	53.91	-32.24	-20.53	-14.94	-22.45
EV/FCF Ratio	-5.93	-27.81	-14.96	-30.91	-14.26	501.38
Debt / Equity Ratio	1.00	0.87	1.48	4.16	1.23	1.41
Debt / EBITDA Ratio	33.70	5.20	-6.17	-3.27	-2.70	-2.00
Debt / FCF Ratio	-2.55	-3.14	-2.39	-4.54	-2.36	42.47
Asset Turnover	0.65	0.53	0.39	0.30	0.23	0.22
Inventory Turnover	0.59	0.60	0.58	0.72	0.47	0.32
Quick Ratio	1.44	2.67	3.18	3.56	5.01	4.90
Current Ratio	2.89	4.20	3.95	4.13	5.75	5.97
Return on Equity (ROE)	-4.02%	19.71%	-86.15%	-107.16%	-49.57%	-70.15%
Return on Assets (ROA)	-0.06%	5.44%	-8.63%	-17.42%	-14.99%	-23.52%
Return on Capital (ROIC)	-0.10%	12.58%	-30.95%	-80.46%	-64.49%	-95.32%
Return on Capital Employed (ROCE)	-0.03%	7.47%	-10.46%	-20.61%	-17.47%	-27.34%
Earnings Yield	-2.73%	1.92%	-6.01%	-6.20%	-5.72%	-4.17%
FCF Yield	-21.25%	-3.59%	-6.38%	-3.13%	-6.14%	0.19%
Buyback Yield / Dilution	-2.07%	-0.67%	-0.57%	-0.26%	-7.26%	-2.93%
Total Shareholder Return	-	-0.67%	-0.57%	-0.26%	-7.26%	-2.93%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.